Other Species / Isoforms
  SMAP1L (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S67-p
VHISRVKsVNLDQWT
0 1
SMAP1L (human) VHISRVKsVNLDQWT S67-p
SMAP1L (mouse) VHISRVKSVNLDQWT S67
SMAP1L (rat) VHISRVKSVNLDQWT S67
K26-ub
LLLEEDNkFCADCQS
0 1
SMAP1L (human) LLLEEDNkFCADCQS K26-ub
SMAP1L (mouse) LLLEEDNKFCADCQS K26
SMAP1L (rat) LLLEEDNKFCADCQS K26
K7-ub
_MTGKSVkDVDRYQA
0 1
SMAP1L (human) _MTGKSVkDVDRYQA K7-ub
SMAP1L (mouse) _MTGKSVKDVDRYQA K7
SMAP1L (rat) _MTGKSVKDVDRYQA K7
K88-ub
MQEMGNGkANRLYEA
0 2
SMAP1L (human) MQEMGNGkANRLYEA K88-ub
SMAP1L (mouse) MQEMGNGKANRLYEA K88
SMAP1L (rat) MQEMGNGKANRLyEA K88
Y93
NGkANRLYEAyLPET
0 2
SMAP1L (human) NGkANRLYEAyLPET Y93
SMAP1L (mouse) NGKANRLYEAyLPET Y93
SMAP1L (rat) NGKANRLyEAYLPET Y93-p
Y96-p
ANRLYEAyLPETFRR
Upstream
0 11
Treatment
  • PD173074
SMAP1L (human) ANRLYEAyLPETFRR Y96-p
SMAP1L (mouse) ANRLYEAyLPETFRR Y96-p
SMAP1L (rat) ANRLyEAYLPETFRR Y96
S127-p
KKKYMDRsLDINAFR
0 2
SMAP1L (human) KKKYMDRsLDINAFR S127-p
SMAP1L (mouse) KKKYMDRSLDINVLR S127
SMAP1L (rat) KKKYMDRSLDINVLR S127
K135-ub
LDINAFRkEKDDKWK
0 1
SMAP1L (human) LDINAFRkEKDDKWK K135-ub
SMAP1L (mouse) LDINVLRKEKDDKWK K135
SMAP1L (rat) LDINVLRKEKDDkWk K135
K140
FRkEKDDKWKRGsEP
0 1
SMAP1L (human) FRkEKDDKWKRGsEP K140
SMAP1L (mouse) LRKEKDDKWKRGNEP K140
SMAP1L (rat) LRKEKDDkWkRGSEP K140-ac
K142
kEKDDKWKRGsEPVP
0 1
SMAP1L (human) kEKDDKWKRGsEPVP K142
SMAP1L (mouse) KEKDDKWKRGNEPAP K142
SMAP1L (rat) KEKDDkWkRGSEPAP K142-ac
S145-p
DDKWKRGsEPVPEkk
0 1
SMAP1L (human) DDKWKRGsEPVPEkk S145-p
SMAP1L (mouse) DDKWKRGNEPAPEKK N145
SMAP1L (rat) DDkWkRGSEPAPEKK S145
K151-ac
GsEPVPEkkLEPVVF
0 1
SMAP1L (human) GsEPVPEkkLEPVVF K151-ac
SMAP1L (mouse) GNEPAPEKKMEPVVF K151
SMAP1L (rat) GSEPAPEKKMEPVVF K151
K152-ub
sEPVPEkkLEPVVFE
0 1
SMAP1L (human) sEPVPEkkLEPVVFE K152-ub
SMAP1L (mouse) NEPAPEKKMEPVVFE K152
SMAP1L (rat) SEPAPEKKMEPVVFE K152
S176-p
DPQLPRKssPKstAP
Upstream
0 1
Treatment
  • MLN8054
SMAP1L (human) DPQLPRKssPKstAP S176-p
SMAP1L (mouse) DAQLPRKSSPKsAAP S176
SMAP1L (rat) DAQLPRKSSPKSAAP S176
S177-p
PQLPRKssPKstAPV
Upstream
0 2
Treatment
  • MLN8054
SMAP1L (human) PQLPRKssPKstAPV S177-p
SMAP1L (mouse) AQLPRKSSPKsAAPV S177
SMAP1L (rat) AQLPRKSSPKSAAPV S177
S180-p
PRKssPKstAPVMDL
Upstream
0 1
Treatment
  • MLN8054
SMAP1L (human) PRKssPKstAPVMDL S180-p
SMAP1L (mouse) PRKSSPKSAAPVMDL S180
SMAP1L (rat) PRKSSPKSAAPVMDL S180
S180
PRKssPKStAPVMDL
0 1
SMAP1L (human) PRKssPKStAPVMDL S180
SMAP1L (mouse) PRKSSPKsAAPVMDL S180-gl
SMAP1L (rat) PRKSSPKSAAPVMDL S180
T181-p
RKssPKstAPVMDLL
Upstream
0 1
Treatment
  • MLN8054
SMAP1L (human) RKssPKstAPVMDLL T181-p
SMAP1L (mouse) RKSSPKsAAPVMDLL A181
SMAP1L (rat) RKSSPKSAAPVMDLL A181
S197
LDAPVACSIANSKtS
0 1
SMAP1L (human) LDAPVACSIANSKtS S197
SMAP1L (mouse) LDAPVACsIANSKTS S197-gl
SMAP1L (rat) LDAPVACSIANSKTS S197
T203-p
CSIANSKtSNTLEkD
0 1
SMAP1L (human) CSIANSKtSNTLEkD T203-p
SMAP1L (mouse) CsIANSKTSNALEKD T203
SMAP1L (rat) CSIANSKTSNALEKD T203
K209-ub
KtSNTLEkDLDLLAs
0 1
SMAP1L (human) KtSNTLEkDLDLLAs K209-ub
SMAP1L (mouse) KTSNALEKDLDLLAs K209
SMAP1L (rat) KTSNALEKDLDLLAS K209
S216-p
kDLDLLAsVPsPSss
0 3
SMAP1L (human) kDLDLLAsVPsPSss S216-p
SMAP1L (mouse) KDLDLLAsVPsPssV S216-p
SMAP1L (rat) KDLDLLASVPsPSSV S216
S219-p
DLLAsVPsPSssGsR
Upstream
0 41
Treatment
  • anti-CD3
  • nocodazole
SMAP1L (human) DLLAsVPsPSssGsR S219-p
SMAP1L (mouse) DLLAsVPsPssVsRK S219-p
SMAP1L (rat) DLLASVPsPSSVSRK S219-p
S221
LAsVPsPSssGsRKV
0 2
SMAP1L (human) LAsVPsPSssGsRKV S221
SMAP1L (mouse) LAsVPsPssVsRKAV S221-p
SMAP1L (rat) LASVPsPSSVSRKAV S221
S222-p
AsVPsPSssGsRKVV
Upstream
0 4
Treatment
  • BI2536
SMAP1L (human) AsVPsPSssGsRKVV S222-p
SMAP1L (mouse) AsVPsPssVsRKAVG S222-p
SMAP1L (rat) ASVPsPSSVSRKAVG S222
S223-p
sVPsPSssGsRKVVG
0 1
SMAP1L (human) sVPsPSssGsRKVVG S223-p
SMAP1L (mouse) sVPsPssVsRKAVGs V223
SMAP1L (rat) SVPsPSSVSRKAVGS V223
S225-p
PsPSssGsRKVVGsM
Upstream
0 6
Treatment
  • BI2536
SMAP1L (human) PsPSssGsRKVVGsM S225-p
SMAP1L (mouse) VPsPssVsRKAVGsM S224-p
SMAP1L (rat) VPsPSSVSRKAVGSM S224
S231-p
GsRKVVGsMPtAGsA
0 4
SMAP1L (human) GsRKVVGsMPtAGsA S231-p
SMAP1L (mouse) VsRKAVGsMPTAGsA S230-p
SMAP1L (rat) VSRKAVGSMPTAGSA S230
T234-p
KVVGsMPtAGsAGsV
0 3
SMAP1L (human) KVVGsMPtAGsAGsV T234-p
SMAP1L (mouse) KAVGsMPTAGsAGsV T233
SMAP1L (rat) KAVGSMPTAGSAGsV T233
S237-p
GsMPtAGsAGsVPEN
Upstream
0 5
Treatment
  • anti-CD3
SMAP1L (human) GsMPtAGsAGsVPEN S237-p
SMAP1L (mouse) GsMPTAGsAGsVPEN S236-p
SMAP1L (rat) GSMPTAGSAGsVPEN S236
S240-p
PtAGsAGsVPENLNL
0 19
SMAP1L (human) PtAGsAGsVPENLNL S240-p
SMAP1L (mouse) PTAGsAGsVPENLNL S239-p
SMAP1L (rat) PTAGSAGsVPENLNL S239-p